Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+75.7%
5Y CAGR+77.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+75.7%/yr
vs +183.9%/yr prior
5Y CAGR
+77.8%/yr
Consistent
Acceleration
-108.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
17.8x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $475.36M | +63.5% |
| 2024 | $290.70M | +82.8% |
| 2023 | $159.01M | +81.6% |
| 2022 | $87.57M | +30.5% |
| 2021 | $67.11M | +151.0% |
| 2020 | $26.74M | +533.0% |
| 2019 | $4.22M | +213.1% |
| 2018 | $1.35M | - |